The drug modeling software market was valued at US$ 6,205.22 million in 2019 and is projected to reach US$ 11,299.85 million by 2027; it is expected to grow at a CAGR of 8.1% during 2020-2027.
The growth of the drug modeling software market is mainly attributed to the factors such as increasing adoption of in-silico modeling tools in drug discovery, and rising economic burden of drug discovery. However, the market is likely to get negatively impacted by the less adoption of drug modeling in emerging countries, during the forecast period.
Drug modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Traditional drug discovery and development method includes various challenges such as capital-intensive, high failure rates, and time-consuming. It involves experimental screening of existing libraries of molecules followed by many rounds of chemical synthesis. The process of drug development, from the discovery of a lead compound to its commercial launch, is estimated to take around 10-15 years along with the investment of a huge amount of money. As per the Pharmaceutical Research and Manufacturers of America, the average cost to research and develop a successful drug is estimated to be US$ 2.6 billion. Moreover, only a small proportion of leads that are selected for further investigation during the initial stages of research are translated into clinical research studies. Over a period, the complexities of drug discovery have increased owing to the increasing size of biologics. As a result, there has been a direct rise in R&D expenditure in the pharmaceutical sector. As per the Pharmaceutical Research and Manufacturers of America, in 2017, biopharmaceutical companies sponsored more than 4,500 clinical trials in the US. These trials accounted for approximately US$ 43 billion; moreover, in 2017, biopharmaceutical companies in the US invested around US$ 97 billion in R&D. At present, the pharmaceutical industry is under tremendous pressure to cope with rising capital requirements in drug discovery research and avoid losses due to drug failure.
Based on product type, the market is segmented into database, software, and others. The software segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Based on application, the global drug modeling software market is segmented into drug discovery and development, medical imaging, computational physiological medicine, predictive analysis of drug targets, disease modeling, simulation software, cellular simulation, and others. The drug discovery and development segment held the largest share of the market in 2019; whereas, the predictive analysis of drug targets segment is estimated to register the highest CAGR in the market during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), European Federation of Pharmaceutical Industry Associations, Pharmaceutical Research, Manufacturers of America, and Organization for Economic Cooperation and Development are among the major primary and secondary sources referred for preparing this report.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Drug Modelling Software Market - By Product Type
1.3.2 Global Drug Modelling Software Market - By Application
1.3.3 Global Drug Modelling Software market - By Geography
2. Drug Modelling Software Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Drug Modelling Software Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Drug Modelling Software Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
5.1.2 Increasing Economic Burden of Drug Discovery
5.2 Key Market Restraints
5.2.1 Less Adoption in Emerging Countries
5.3 Key Market Opportunities
5.3.1 Strategic Activities by Market Players
5.4 Future Trends
5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.5 Impact analysis
6. Drug Modelling Software Market - Global Analysis
6.1 Global Drug Modelling Software Market Revenue Forecast And Analysis
6.2 Global Drug Modelling Software Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Drug Modelling Software Market - By Product Type
7.1 Overview
7.2 Drug Modelling Software Market, by Product Type, 2019 and 2027 (%)
7.3 Database
7.3.1 Overview
7.3.2 Database: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Software
7.5.1 Overview
7.5.2 Software: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Other Product Types
7.6.1 Overview
7.6.2 Other Product Types: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8. Drug Modelling Software Market Analysis - By Application
8.1 Overview
8.2 Drug Modelling Software Market Revenue Share, by Application (2019 and 2027)
8.3 Drug Discovery and Development
8.3.1 Overview
8.3.2 Drug Discovery and Development: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Computational Physiological Medicine
8.4.1 Overview
8.4.2 Computational Physiological Medicine: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Disease Modelling
8.5.1 Overview
8.5.2 Disease Modelling: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Medical Imaging
8.6.1 Overview
8.6.2 Medical Imaging: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Predictive Analysis of Drug Targets
8.7.1 Overview
8.7.2 Predictive Analysis of Drug Targets: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8.8 Simulation Software
8.8.1 Overview
8.8.2 Simulation Software: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8.9 Cellular Simulation
8.9.1 Overview
8.9.2 Cellular Simulation: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
9. Drug Modelling Software Market Analysis And Forecasts To 2027 - Geographical Analysis
9.1 North America: Drug Modelling Software Market
9.1.1 Overview
9.1.2 North America: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
9.1.6 US: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.7 Canada: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.8 Mexico: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.9 North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
9.2 Europe: Drug Modelling Software Market
9.2.1 Overview
9.2.2 Europe: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.2.7 France: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 France: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 France: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.7.3 France: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.2.8 UK: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 UK: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 UK: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.8.3 UK: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.2.9 Italy: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Italy: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Italy: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Italy: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.2.10 Spain: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Spain: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.3 Asia-Pacific: Drug Modelling Software Market
9.3.1 Overview
9.3.2 Asia-Pacific: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia-Pacific Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.3.4 Asia-Pacific Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.3.5 Asia-Pacific: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
9.4.1 China: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.1.1 China: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.1.2 China Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.1.3 China Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.2 Japan: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.2.1 Japan: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.2.2 Japan Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.2.3 Japan Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.3 India: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.3.1 India: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.3.2 India Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.3.3 India Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.4 South Korea: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.4.1 South Korea: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.4.2 South Korea Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.4.3 South Korea Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.5 Australia: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.1 Australia: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.4.5.2 Australia Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.5.3 Australia Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.5 Middle East & Africa: Drug Modelling Software Market
9.5.1 Overview
9.5.2 Middle East & Africa: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
9.5.3 Middle East & Africa Drug Modelling Software Market, by Product Type- Revenue and Forecast to 2027 (USD Million)
9.5.4 Middle East & Africa Drug Modelling Software Market, by Application- Revenue and Forecast to 2027 (USD Million)
9.5.5 Middle East & Africa: Drug Modelling Software Market, by Country, 2018 & 2027 (%)
9.5.6 Saudi Arabia: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Saudi Arabia: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Saudi Arabia Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Saudi Arabia Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.5.7 UAE: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 UAE: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 UAE Drug Modelling Software Market, by Product Type- Revenue and Forecast to 2027 (USD Million)
9.5.7.3 UAE Drug Modelling Software Market, by Product Type- Revenue and Forecast to 2027 (USD Million)
9.5.8 South Africa: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.1 South Africa: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.2 South Africa Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.5.8.3 South Africa Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.6 South and Central America: Drug Modelling Software Market
9.6.1 Overview
9.6.2 South and Central America: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.6.3 South and Central America Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.6.4 South and Central America Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.6.5 South and Central America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
9.6.6 Brazil: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.6.6.1 Brazil: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.6.6.2 Brazil Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.6.6.3 Brazil Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.6.7 Argentina: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.6.7.1 Argentina: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.6.7.2 Argentina Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.6.7.3 Argentina Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic On Global Drug Modelling Software Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Drug Modelling Software Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Crown Bioscience Inc (JSR life science)
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Chemical Computing Group ULC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Nimbus Therapeutics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Schrödinger, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Genedata AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Biognos AB
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Compugen Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Dassault Systèmes
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Acellera
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.10 Leadscope, Inc (Instem)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 3. US: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 4. US: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. Canada: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 6. Canada: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 9. Europe: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Europe: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 11. Germany: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Germany: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 13. France: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 14. France: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. UK: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 16. UK: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Italy: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 19. Spain: Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 20. Spain: Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 21. Asia-Pacific Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Asia-Pacific Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 23. China Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 24. China Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. Japan Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 26. Japan Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 27. India Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 28. India Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 31. Australia Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 32. Australia Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 33. Middle East & Africa Drug Modelling Software Market, by Product Type- Revenue and Forecast to 2027 (USD Million)
Table 34. Middle East & Africa Drug Modelling Software Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 35. Saudi Arabia Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 36. Saudi Arabia Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 37. UAE Drug Modelling Software Market, by Product Type- Revenue and Forecast to 2027 (USD Million)
Table 38. UAE Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 39. South Africa Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 40. South Africa Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 41. South and Central America Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 42. South and Central America Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 43. Brazil Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 44. Brazil Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 45. Argentina Drug Modelling Software Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 46. Argentina Drug Modelling Software Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 47. Organic Developments Done By Companies
Table 48. Inorganic Developments Done By Companies
Table 49. Glossary of Terms, Drug Modelling Software Market
The List of Companies - Drug Modeling Software Market
1. Crown Bioscience Inc.
2. Chemical Computing Group Ulc
3. Nimbus Therapeutics
4. Schrödinger, Inc.
5. Dassault Systèmes
6. Genedata Ag
7. Biognos Ab
8. Compugen Ltd
9. Acellera ltd.
10. Leadscope, Inc